Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Protect Pharmaceutical Corporation    PRTT

PROTECT PHARMACEUTICAL CORPORATION

(PRTT)
SummaryQuotesChartsNewsCompany 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector news

Protect Pharmaceutical : Agrees to be Acquired by Novgorod Group

09/15/2020 | 09:16am EST

Sevnica, Slovenia, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Protect Pharmaceutical Corp “OTC:(PRTT)” is pleased to announce its agreement to be acquired OOO Novgorod Group (“Novgorod” - see http://nowgorodprodukt.ru) which specializes in the production and sale of sugar, flour, cereals and other groceries. Actively successful in the Russian food market for over 15 years, Novgorod operates with such retail giants as AO Tander (Magnit), X5 Retail Group, OOO Lenta, AO Dixy South and others. Novgorod showed 9.7 Billion (RUB) (US $128,913,000 as of release) in revenues for 2019. Second quarter 2020 revenues were 3.7 (RUB) (US $49,173,000.00 as of release).

Under the agreed terms, Novgorod will acquire control of Protect Pharmaceutical Corp upon completion of the transition of Novgorod’s reporting to GAAP accounting standards. Protect Pharmaceutical Corp will continue to operate as a public company and the eventual resulting combined company will continue to trade under the symbol PRTT.

Protect Pharmaceutical Corp and Novgorod foresee incredible synergies from the transaction. Novgorod intends to use Protect Pharmaceutical products for its own production and Protect Pharmaceutical Corp will harness the market power of Novgorod as an incredible opportunity for expansion.

“This is an amazing milestone for Protect Pharmaceutical. We have been searching for the right partner to expand and grow and in Novgorod we have found it,” states Angela Savcenco, Director of European Operations.

Forward-Looking Statements: This press release contains “forward-looking statements” within the meaning of Section 21E of the Securities Exchange Act of 1934. Except for historical matters contained herein, statements made in this press release are forward-looking statements. Without limiting the generality of the foregoing, words such as “may”, “will”, “to”, “plan”, “expect”, “believe”, “anticipate”, “intend”, “could”, “would”, “estimate,” or “continue”, or the negative other variations thereof or comparable terminology are intended to identify forward-looking statements. Forward-looking statements involve known and unknown risk, uncertainties and other factors which may cause our actual results, performance or achievements to be materially different from any future results, performance or achievements expressed or implied by the forward-looking statements. Also, forward-looking statements represent our management’s beliefs and assumptions only as of the date hereof. Additional information regarding the factors that may cause actual results to differ materially from these forward-looking statements is available in the Company's filings with OTC Markets. Except as required by law, we assume no obligation to update these forward-looking statements publicly or to update the reasons actual results could differ materially from those anticipated in these forward-looking statements, even if new information becomes available in the future.

For more information contact:
Protect Pharmaceutical Corp.
(801) 432-0405
info@agropharmacy.com


Source: PROTECT PHARMACEUTICAL Corp

2020 GlobeNewswire, Inc., source Press Releases

All news about PROTECT PHARMACEUTICAL CORPORATION
2020PROTECT PHARMACEUTICAL : Agrees to be Acquired by Novgorod Group
AQ
2020Protect Pharmaceutical's Agrees to be Acquired by Novgorod Group
GL
2020Protect Pharmaceutical's Agropharm A Fertilizer Shown To Increase Crop Yields..
GL
2020Protect Pharmaceutical Announces Construction of Two New Agropharm Production..
GL
2020PROTECT PHARMACEUTICAL : Successfully Deploys Agropharm A, Obtains DTC Eligibili..
AQ
2020PROTECT PHARMACEUTICAL COMMENCES PRO : Cannabis-Based “Green Wine”
AQ
2020Protect Pharmaceutical Acquires 60 Hectares in Selva Girona to Showcase Agrop..
GL
2020Protect Pharmaceutical Acquires the Hotel Albons in Spain and Adds New Direct..
GL
2020PROTECT PHARMACEUTICAL : Acquires Mastnak Winery, Solidifying Award-Winning Wine..
AQ
2018AES and OnliFunds Launches OnliChain focused $250 million Fund.
GL
More news
Chart PROTECT PHARMACEUTICAL CORPORATION
Duration : Period :
Protect Pharmaceutical Corporation Technical Analysis Chart | PRTT | US74364W2035 | MarketScreener
Managers and Directors
NameTitle
Alan Crooks Chief Executive Officer & Director
Sector and Competitors
1st jan.Capitalization (M$)
PROTECT PHARMACEUTICAL CORPORATION8.33%26
JOHNSON & JOHNSON1.86%421 997
ROCHE HOLDING AG2.48%305 385
NOVARTIS AG1.97%218 041
MERCK & CO., INC.1.93%210 954
PFIZER INC.-0.30%203 993